Henan Taloph Pharmaceutical Stock (600222) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

600222 Henan Taloph Pharmaceutical Stock

Watchlist

5.08
+0.02+0.40%

Market Closed Jan 17 15:00 CST

2.92BMarket Cap32.56P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Solid Earnings May Not Tell The Whole Story For Henan Taloph Pharmaceutical StockLtd (SHSE:600222)
Simply Wall StOct 31, 2024 18:18 ET
There's No Escaping Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Muted Revenues
Simply Wall StOct 1, 2024 01:38 ET
While Shareholders of Henan Taloph Pharmaceutical StockLtd (SHSE:600222) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown
Simply Wall StAug 6, 2024 18:27 ET
Investors Shouldn't Be Too Comfortable With Henan Taloph Pharmaceutical StockLtd's (SHSE:600222) Earnings
Simply Wall StApr 3, 2024 19:26 ET
Why Investors Shouldn't Be Surprised By Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) 30% Share Price Plunge
Simply Wall StFeb 5, 2024 17:37 ET
Little Excitement Around Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues
Simply Wall StOct 30, 2023 19:59 ET

Comments

Moomoo AI

Feb 5, 2024 17:35

Market expectations of a decline in Henan Taloph Pharmaceutical's revenue performance and slower growth compared to the industry average may contribute to its low P/S ratio. Shareholders' wariness of the company's ability to keep up with industry growth could be a factor in the declining share price.

Why Investors Shouldn't Be Surprised By Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) 30% Share Price Plunge

Moomoo AI

Oct 30, 2023 19:13

Henan Taloph's lower P/S ratio may be justified due to slower growth rates than industry rivals. Doubts about the company's ability to maintain robust growth in line with industry may hinder share price recovery.